Mesothelioma (malignant)

Definition

Malignant mesothelioma is a cancerous tumor of the pleura (lining of the lung and chest cavity) or peritoneum (lining of the abdomen) that is almost always caused by sustained exposure to asbestos.

Causes, incidence, and risk factors

Malignant mesothelioma is a diffuse tumor that affects men more frequently than women. Sustained exposure to asbestos is the biggest risk factor. It can take 20 to 50 years or even longer between exposure to asbestos and onset of the disease.

The median age of diagnosis is 60. The tumor can spread rapidly to involve the pericardium (sac around the heart), mediastinum, and the other pleura. Worsening pain and shortness of breath can occur. The tumor is usually associated with a pleural effusion.

It can be hard to distinguish between this type of tumor and other conditions and tumors of the pleura, even when experienced pathologists are viewing biopsy samples.

Symptoms

• Shortness of breath
• Chest pain
• Cough
• Weight loss

Signs and tests

• Chest x-ray showing tumor and possibly showing pleural effusion (which may be bloody)
• Thoracic CT
• Cytology from pleural fluid
• Open lung biopsy

Treatment

Results of treatment for malignant mesothelioma have been disappointing. When found early, surgery may cure it. Having chemotherapy and radiation before the surgery may help increase the chance of being cured.

When the disease is too advanced for surgery, chemotherapy or radiation may be used to reduce symptoms, but being cured is usually not possible.

A 2002 study showed that a chemotherapy regimen of two drugs -- cisplatin and pemetrexed -- appears promising in improving survival and decreasing symptoms. Other new chemotherapy drugs and combinations of drugs are gradually improving the treatment of malignant mesothelioma. Consider participating in a clinical trial (test of new treatments), which may give you additional treatment options.

Supportive treatment (such as pain relief and oxygen) may also help to relieve symptoms.

Support Groups

The stress of illness can often be helped by joining a support group where members share common experiences and problems. See cancer - support group and lung disease - support group.

Expectations (prognosis)

The median survival time varies from 4 to 18 months in different studies. However, prognosis depends on the stage of the tumor and whether surgical removal of the tumor is an option.

Complications

Rapid spread of the tumor to other organs is a complication.

Calling your health care provider

Call for an appointment with your health care provider if you have symptoms suggestive of malignant mesothelioma.

Prevention

Avoid exposure to asbestos.

Illustrations

Respiratory system

Page Content:

malignant mesothelioma; malignant pleural mesothelioma; attorney austin benign malignant mesothelioma; survival stage iii malignant mesothelioma; 2 interleukin malignant mesothelioma treatment; diffuse malignant pleural mesothelioma; malignant mesothelioma pleural rate survival; malignant mesothelioma peritoneal; malignant mesothelioma research; attorney austin malignant mesothelioma; diffuse malignant peritoneal mesothelioma; attorney austin malignant pleural mesothelioma; diffuse malignant mesothelioma; desmoplastic malignant mesothelioma; attorney austin malignant mesothelioma symptom; diagnosis malignant mesothelioma; lawyer malignant mesothelioma; epithelial malignant mesothelioma; attorney austin malignant mesothelioma pericardial; attorney malignant mesothelioma; attorney austin desmoplastic malignant mesothelioma; malignant mesothelioma body cavity; malignant and mesothelioma and coding; asbestos.com malignant mesothelioma site; attorney chicago malignant mesothelioma symptom; asbestos attorney benign malignant mesothelioma; 55.95 malignant mesothelioma pleural; california malignant mesothelioma pleural